Opinion · 1 Dec 2025
PerspectivePublished 29 Jan 2024
Evaluating the Cost-effectiveness of Risk Factor-based Lung Cancer Screening Programs
More from this journal
The newest in Pharmacoeconomics: Open Access.
Short communication · 1 Dec 2025
Preventive Drugs for Older Adults: Health and Economic Benefits
Brief report · 29 Nov 2025
Value Assessment Of High-cost Specialty Drugs
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmacoeconomics: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hisao Asamura”

